Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that the Company has appointed Darryl Vleeming as its new Chief Information Officer (“CIO”).
Mr. Vleeming comes to Aurora with over 20 years of experience in Senior IT leadership, project delivery, and IT strategic planning at publicly traded international corporations, with a specific focus on driving business value. Prior to joining Aurora, Mr. Vleeming spent eight years, lastly as Vice President, IS and Chief Information Officer, at Capital Power Corporation, a $2.5 billion, TSX listed independent power producer. Among other responsibilities, Mr. Vleeming was in charge of the division running the corporation’s mission critical IT systems, general IT asset management, as well as development of the corporation’s strategic technology vision to drive competitive differentiation. Prior to Capital Power, Mr. Vleeming was Manager of Systems Development at EPCOR, one of Canada’s top providers of energy and energy-related services and products in Alberta, Ontario, and the United States.
Mr Vleeming sits on the Board of Directors of a number of not-for-profit and charitable organizations, including Cybera, which is responsible for overseeing the development of Alberta’s cyber infrastructure, and The Rainbow Society of Alberta, a registered charity dedicated to fulfilling wishes of Alberta children with chronic or life threatening illnesses. Mr. Vleeming holds an Executive MBA from the University of Athabasca, and a Computer Systems Technology Honours Diploma from the Northern Alberta Institute of Technology (NAIT).
“The newly created position of CIO reflects the degree to which leadership in technology and innovation is part of our DNA, as well as central to our global expansion strategy,” said Terry Booth, CEO. “With his exceptional track record of identifying technological opportunities and executing technology-driven strategies, we believe Darryl is the right person to help us scale up Aurora’s e-commerce platform, establish systems to manage the vast amount of data we generate, and ensure tight alignment across our domestic and international operations. We are very pleased to have attracted a leader of his calibre, and look forward to his contributions to driving accelerated growth.”
Milestone Payments
Additionally, the Company issued 1,369,072 common shares, at a deemed price of $2.54 per common share and 469,044 common shares at a deemed price of $2.98 per common share to the vendors of CanvasRx Inc. (“CanvasRx”) in accordance with CanvasRx achieving certain earn-out payment milestones for the period ended September 30, 2017, as set out in the share purchase agreement previously announced on August 10, 2016.
credit:420intel.com
